Cargando…

SARS-CoV-2 Testing, Prevalence, and Predictors of COVID-19 in Patients with Inflammatory Bowel Disease in Northern California

Detalles Bibliográficos
Autores principales: Gubatan, John, Levitte, Steven, Balabanis, Tatiana, Patel, Akshar, Sharma, Arpita, Habtezion, Aida
Formato: Online Artículo Texto
Lenguaje:English
Publicado: by the AGA Institute 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204754/
https://www.ncbi.nlm.nih.gov/pubmed/32387541
http://dx.doi.org/10.1053/j.gastro.2020.05.009
_version_ 1783530113054277632
author Gubatan, John
Levitte, Steven
Balabanis, Tatiana
Patel, Akshar
Sharma, Arpita
Habtezion, Aida
author_facet Gubatan, John
Levitte, Steven
Balabanis, Tatiana
Patel, Akshar
Sharma, Arpita
Habtezion, Aida
author_sort Gubatan, John
collection PubMed
description
format Online
Article
Text
id pubmed-7204754
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher by the AGA Institute
record_format MEDLINE/PubMed
spelling pubmed-72047542020-05-07 SARS-CoV-2 Testing, Prevalence, and Predictors of COVID-19 in Patients with Inflammatory Bowel Disease in Northern California Gubatan, John Levitte, Steven Balabanis, Tatiana Patel, Akshar Sharma, Arpita Habtezion, Aida Gastroenterology Brief Communication by the AGA Institute 2020-09 2020-05-07 /pmc/articles/PMC7204754/ /pubmed/32387541 http://dx.doi.org/10.1053/j.gastro.2020.05.009 Text en © 2020 by the AGA Institute. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Brief Communication
Gubatan, John
Levitte, Steven
Balabanis, Tatiana
Patel, Akshar
Sharma, Arpita
Habtezion, Aida
SARS-CoV-2 Testing, Prevalence, and Predictors of COVID-19 in Patients with Inflammatory Bowel Disease in Northern California
title SARS-CoV-2 Testing, Prevalence, and Predictors of COVID-19 in Patients with Inflammatory Bowel Disease in Northern California
title_full SARS-CoV-2 Testing, Prevalence, and Predictors of COVID-19 in Patients with Inflammatory Bowel Disease in Northern California
title_fullStr SARS-CoV-2 Testing, Prevalence, and Predictors of COVID-19 in Patients with Inflammatory Bowel Disease in Northern California
title_full_unstemmed SARS-CoV-2 Testing, Prevalence, and Predictors of COVID-19 in Patients with Inflammatory Bowel Disease in Northern California
title_short SARS-CoV-2 Testing, Prevalence, and Predictors of COVID-19 in Patients with Inflammatory Bowel Disease in Northern California
title_sort sars-cov-2 testing, prevalence, and predictors of covid-19 in patients with inflammatory bowel disease in northern california
topic Brief Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204754/
https://www.ncbi.nlm.nih.gov/pubmed/32387541
http://dx.doi.org/10.1053/j.gastro.2020.05.009
work_keys_str_mv AT gubatanjohn sarscov2testingprevalenceandpredictorsofcovid19inpatientswithinflammatoryboweldiseaseinnortherncalifornia
AT levittesteven sarscov2testingprevalenceandpredictorsofcovid19inpatientswithinflammatoryboweldiseaseinnortherncalifornia
AT balabanistatiana sarscov2testingprevalenceandpredictorsofcovid19inpatientswithinflammatoryboweldiseaseinnortherncalifornia
AT patelakshar sarscov2testingprevalenceandpredictorsofcovid19inpatientswithinflammatoryboweldiseaseinnortherncalifornia
AT sharmaarpita sarscov2testingprevalenceandpredictorsofcovid19inpatientswithinflammatoryboweldiseaseinnortherncalifornia
AT habtezionaida sarscov2testingprevalenceandpredictorsofcovid19inpatientswithinflammatoryboweldiseaseinnortherncalifornia